SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-017402
Filing Date
2020-07-14
Accepted
2020-07-14 09:10:11
Documents
2
Period of Report
2020-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124115-8k_citiuspharma.htm 8-K 19855
2 PRESS RELEASE DATED JULY 14, 2020. ea124115ex99-1_citiusphar.htm EX-99.1 13663
  Complete submission text file 0001213900-20-017402.txt   34939
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 201026446
SIC: 2834 Pharmaceutical Preparations